Skip to main content
SpringerLink
Log in

Adrenal Imaging

  • Chapter
Interventional Urology

  • 1337 Accesses

Abstract

The adrenal glands are vital organs in homeostatic regulations and physiologic functions of the entire body. Adrenal diseases exhibit a broad range of pathology and deserve careful evaluation. Imaging features and metabolic characteristics of adrenal lesions are crucial in their diagnosis. Some adrenal diseases, such as myelolipomas and simple cysts, are asymptomatic and require no treatment. Many adrenal lesions are metabolically active and excessively secrete hormones. Lastly, malignant tumors affecting the adrenal glands either arise primarily, such as adrenocortical carcinoma and malignant pheochromocytoma, or metastasize from other cancers. Understanding of adrenal pathophysiology, diagnostic characteristics, and therapeutic options enables one to properly manage patients affected by adrenal disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Avisse C, Marcus C, Patey M, Ladam-Marcus V, Delattre JF, Flament JB. Surgical anatomy and embryology of the adrenal glands. Surg Clin North Am. 2000;80(1):403–15.

    Article  CAS  PubMed  Google Scholar 

  2. Kutikov A, Crispen PL, Uzzo RG. Pathophysiology, evaluation, and medical management of adrenal disorders. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 10th ed. Philadelphia: Elsevier Saunders; 2011. p. 1685–736.

    Google Scholar 

  3. Sahdev A, Reznek RH. Adrenal imaging. In: Grainger & Allison’s diagnostic radiology. Edinburgh: Churchill Livingstone Elsevier; 2014;(44).

    Google Scholar 

  4. Kutikov A, Mehrazin R, Uzzo RG. Assessment and management of an adrenal mass in urological practice. Linthicum: American Urological Association; 2014. p. 194–9.

    Google Scholar 

  5. Barwick TD, Malhotra A, Webb JA, Savage MO, Reznek RH. Embryology of the adrenal glands and its relevance to diagnostic imaging. Clin Radiol. 2005;60(9):953–9.

    Article  CAS  PubMed  Google Scholar 

  6. Kempná P, Flück CE. Adrenal gland development and defects. Best Pract Res Clin Endocrinol Metab. 2008;22(1):77–93.

    Article  PubMed  CAS  Google Scholar 

  7. Arlt W, Stewart PM. Adrenal corticosteroid biosynthesis, metabolism, and action. Endocrinol Metab Clin North Am. 2005;34(2):293–313, viii.

    Article  CAS  PubMed  Google Scholar 

  8. White PC. Disorders of aldosterone biosynthesis and action. N Engl J Med. 1994;331(4):250–8.

    Article  CAS  PubMed  Google Scholar 

  9. Jacobson L. Hypothalamic-pituitary-adrenocortical axis regulation. Endocrinol Metab Clin North Am. 2005;34(2):271–92, vii.

    Article  CAS  PubMed  Google Scholar 

  10. Stewart PM, Krone NP. The adrenal cortex. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, editors. Williams textbook of endocrinology. 12th ed. Philadelphia: Saunders Elsevier; 2011.

    Google Scholar 

  11. de Diego AM, Gandía L, García AG. A physiological view of the central and peripheral mechanisms that regulate the release of catecholamines at the adrenal medulla. Acta Physiol (Oxf). 2008;192(2):287–301.

    Article  CAS  Google Scholar 

  12. Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev. 2004;56(3):331–49.

    Article  CAS  PubMed  Google Scholar 

  13. Young WF. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med. 2007;356(6):601–10.

    Article  CAS  PubMed  Google Scholar 

  14. Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol. 2008;190(5):1163–8.

    Article  PubMed  Google Scholar 

  15. Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003;149(4):273–85.

    Article  CAS  PubMed  Google Scholar 

  16. Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, et al. Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med. 2003;138(5):424–9.

    Article  PubMed  Google Scholar 

  17. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocr Rev. 1995;16(4):460–84.

    CAS  PubMed  Google Scholar 

  18. Lenert JT, Barnett CC, Kudelka AP, Sellin RV, Gagel RF, Prieto VG, et al. Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. Surgery. 2001;130(6):1060–7.

    Article  CAS  PubMed  Google Scholar 

  19. Young WF. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am. 2000;29(1):159–85.

    Article  PubMed  Google Scholar 

  20. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Alì A, et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab. 2000;85(2):637–44.

    CAS  PubMed  Google Scholar 

  21. Angeli A, Osella G, Alì A, Terzolo M. Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm Res. 1997;47(4–6):279–83.

    Article  CAS  PubMed  Google Scholar 

  22. Cicala MV, Sartorato P, Mantero F. Incidentally discovered masses in hypertensive patients. Best Pract Res Clin Endocrinol Metab. 2006;20(3):451–66.

    Article  PubMed  Google Scholar 

  23. Thompson GB, Young WF. Adrenal incidentaloma. Curr Opin Oncol. 2003;15(1):84–90.

    Article  PubMed  Google Scholar 

  24. Libè R, Dall’Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P, Ambrosi B. Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol. 2002;147(4):489–94.

    Article  PubMed  Google Scholar 

  25. Singh PK, Buch HN. Adrenal incidentaloma: evaluation and management. J Clin Pathol. 2008;61(11):1168–73.

    Article  CAS  PubMed  Google Scholar 

  26. Welch TJ, Sheedy PF, Stephens DH, Johnson CM, Swensen SJ. Percutaneous adrenal biopsy: review of a 10-year experience. Radiology. 1994;193(2):341–4.

    Article  CAS  PubMed  Google Scholar 

  27. Harisinghani MG, Maher MM, Hahn PF, Gervais DA, Jhaveri K, Varghese J, et al. Predictive value of benign percutaneous adrenal biopsies in oncology patients. Clin Radiol. 2002;57(10):898–901.

    Article  CAS  PubMed  Google Scholar 

  28. Suzuki Y, Sasagawa, Suzuki H, Izumi T, Kaneko H, Nakada T. The role of ultrasonography in the detection of adrenal masses: comparison with computed tomography and magnetic resonance imaging. Int Urol Nephrol. 2001;32(3):303–6.

    Article  CAS  PubMed  Google Scholar 

  29. Heinz-Peer G, Memarsadeghi M, Niederle B. Imaging of adrenal masses. Curr Opin Urol. 2007;17(1):32–8.

    Article  PubMed  Google Scholar 

  30. Boland GW, Blake MA, Hahn PF, Mayo-Smith WW. Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology. 2008;249(3):756–75.

    Article  PubMed  Google Scholar 

  31. Boland GW. Adrenal imaging: why, when, what, and how? Part 2. What technique? AJR Am J Roentgenol. 2011;196(1):W1–5.

    Article  PubMed  Google Scholar 

  32. Korobkin M, Giordano TJ, Brodeur FJ, Francis IR, Siegelman ES, Quint LE, et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology. 1996;200(3):743–7.

    Article  CAS  PubMed  Google Scholar 

  33. Lee MJ, Hahn PF, Papanicolaou N, Egglin TK, Saini S, Mueller PR, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology. 1991;179(2):415–8.

    Article  CAS  PubMed  Google Scholar 

  34. Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol. 1998;171(1):201–4.

    Article  CAS  PubMed  Google Scholar 

  35. Halefoglu AM, Bas N, Yasar A, Basak M. Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study. Eur J Radiol. 2010;73(3):643–51.

    Article  PubMed  Google Scholar 

  36. Ho LM, Paulson EK, Brady MJ, Wong TZ, Schindera ST. Lipid-poor adenomas on unenhanced CT: does histogram analysis increase sensitivity compared with a mean attenuation threshold? AJR Am J Roentgenol. 2008;191(1):234–8.

    Article  PubMed  Google Scholar 

  37. Korobkin M, Brodeur FJ, Yutzy GG, Francis IR, Quint LE, Dunnick NR, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol. 1996;166(3):531–6.

    Article  CAS  PubMed  Google Scholar 

  38. Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Londy F. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol. 1998;170(3):747–52.

    Article  CAS  PubMed  Google Scholar 

  39. Peña CS, Boland GW, Hahn PF, Lee MJ, Mueller PR. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology. 2000;217(3):798–802.

    Article  PubMed  Google Scholar 

  40. Sangwaiya MJ, Boland GW, Cronin CG, Blake MA, Halpern EF, Hahn PF. Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT – 10-minute delayed imaging protocol revisited in a large patient cohort. Radiology. 2010;256(2):504–10.

    Article  PubMed  Google Scholar 

  41. Davarpanah AH, Israel GM. MR imaging of the kidneys and adrenal glands. Radiol Clin North Am. 2014;52(4):779–98.

    Article  PubMed  Google Scholar 

  42. Mayo-Smith WW, Lee MJ, McNicholas MM, Hahn PF, Boland GW, Saini S. Characterization of adrenal masses (<5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR Am J Roentgenol. 1995;165(1):91–5.

    Article  CAS  PubMed  Google Scholar 

  43. Fujiyoshi F, Nakajo M, Fukukura Y, Tsuchimochi S. Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation. AJR Am J Roentgenol. 2003;180(6):1649–57.

    Article  PubMed  Google Scholar 

  44. Israel GM, Korobkin M, Wang C, Hecht EN, Krinsky GA. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR Am J Roentgenol. 2004;183(1):215–9.

    Article  PubMed  Google Scholar 

  45. Haider MA, Ghai S, Jhaveri K, Lockwood G. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? Radiology. 2004;231(3):711–6.

    Article  PubMed  Google Scholar 

  46. Savci G, Yazici Z, Sahin N, Akgöz S, Tuncel E. Value of chemical shift subtraction MRI in characterization of adrenal masses. AJR Am J Roentgenol. 2006;186(1):130–5.

    Article  PubMed  Google Scholar 

  47. Inan N, Arslan A, Akansel G, Anik Y, Balci NC, Demirci A. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses. Eur J Radiol. 2008;65(1):154–62.

    Article  PubMed  Google Scholar 

  48. Blake MA, Slattery JM, Kalra MK, Halpern EF, Fischman AJ, Mueller PR, et al. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy – initial experience. Radiology. 2006;238(3):970–7.

    Article  PubMed  Google Scholar 

  49. Chong S, Lee KS, Kim HY, Kim YK, Kim BT, Chung MJ, et al. Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficacy and interpretation pitfalls. Radiographics. 2006;26(6):1811–24; discussion 24–6.

    Article  PubMed  Google Scholar 

  50. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915–42.

    Article  CAS  PubMed  Google Scholar 

  51. Zettinig G, Mitterhauser M, Wadsak W, Becherer A, Pirich C, Vierhapper H, et al. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate. Eur J Nucl Med Mol Imaging. 2004;31(9):1224–30.

    Article  PubMed  Google Scholar 

  52. Blake MA, Prakash P, Cronin CG. PET/CT for adrenal assessment. AJR Am J Roentgenol. 2010;195(2):W91–5.

    Article  PubMed  Google Scholar 

  53. Minn H, Salonen A, Friberg J, Roivainen A, Viljanen T, Långsjö J, et al. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG. J Nucl Med. 2004;45(6):972–9.

    CAS  PubMed  Google Scholar 

  54. Kaltsas G, Korbonits M, Heintz E, Mukherjee JJ, Jenkins PJ, Chew SL, et al. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab. 2001;86(2):895–902.

    Article  CAS  PubMed  Google Scholar 

  55. Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, et al. The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract. 2009;15 Suppl 1:1–20.

    Article  PubMed  Google Scholar 

  56. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al. The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(5):1526–40.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  57. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293–300.

    Article  CAS  PubMed  Google Scholar 

  58. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89(3):1045–50.

    Article  CAS  PubMed  Google Scholar 

  59. Anagnostis P, Karagiannis A, Tziomalos K, Kakafika AI, Athyros VG, Mikhailidis DP. Adrenal incidentaloma: a diagnostic challenge. Hormones (Athens). 2009;8(3):163–84.

    Article  Google Scholar 

  60. Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf). 2007;66(5):607–18.

    Article  CAS  Google Scholar 

  61. Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc. 1981;56(6):354–60.

    CAS  PubMed  Google Scholar 

  62. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab. 2007;3(2):92–102.

    Article  PubMed  Google Scholar 

  63. Grossman A, Pacak K, Sawka A, Lenders JW, Harlander D, Peaston RT, et al. Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus? Ann N Y Acad Sci. 2006;1073:332–47.

    Article  CAS  PubMed  Google Scholar 

  64. Perry CG, Sawka AM, Singh R, Thabane L, Bajnarek J, Young WF. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma. Clin Endocrinol (Oxf). 2007;66(5):703–8.

    Article  CAS  Google Scholar 

  65. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287(11):1427–34.

    Article  CAS  PubMed  Google Scholar 

  66. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet. 2006;367(9522):1605–17.

    Article  CAS  PubMed  Google Scholar 

  67. Porterfield JR, Thompson GB, Young WF, Chow JT, Fryrear RS, van Heerden JA, et al. Surgery for Cushing’s syndrome: an historical review and recent ten-year experience. World J Surg. 2008;32(5):659–77.

    Article  PubMed  Google Scholar 

  68. Lacroix A, Bourdeau I. Bilateral adrenal Cushing’s syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease. Endocrinol Metab Clin North Am. 2005;34(2):441–58, x.

    Article  CAS  PubMed  Google Scholar 

  69. Feelders RA, Hofland LJ, de Herder WW. Medical treatment of Cushing’s syndrome: adrenal-blocking drugs and ketoconazole. Neuroendocrinology. 2010;92 Suppl 1:111–5.

    Article  CAS  PubMed  Google Scholar 

  70. Kamenický P, Droumaguet C, Salenave S, Blanchard A, Jublanc C, Gautier JF, et al. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing’s syndrome. J Clin Endocrinol Metab. 2011;96(9):2796–804.

    Article  PubMed  CAS  Google Scholar 

  71. Young WF. Endocrine hypertension. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, editors. Williams textbook of endocrinology. 12th ed. Philadelphia: Saunders Elsevier; 2011.

    Google Scholar 

  72. Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, et al. Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension. 2006;48(2):232–8.

    Article  CAS  PubMed  Google Scholar 

  73. Tanabe A, Naruse M, Naruse K, Hase M, Yoshimoto T, Tanaka M, et al. Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens Res. 1997;20(2):85–90.

    Article  CAS  PubMed  Google Scholar 

  74. Young WF. Primary aldosteronism: management issues. Ann N Y Acad Sci. 2002;970:61–76.

    Article  PubMed  Google Scholar 

  75. Mulatero P, Bertello C, Rossato D, Mengozzi G, Milan A, Garrone C, et al. Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab. 2008;93(4):1366–71.

    Article  CAS  PubMed  Google Scholar 

  76. Toniato A, Bernante P, Rossi GP, Pelizzo MR. The role of adrenal venous sampling in the surgical management of primary aldosteronism. World J Surg. 2006;30(4):624–7.

    Article  PubMed  Google Scholar 

  77. Meyer A, Brabant G, Behrend M. Long-term follow-up after adrenalectomy for primary aldosteronism. World J Surg. 2005;29(2):155–9.

    Article  PubMed  Google Scholar 

  78. Lumachi F, Ermani M, Basso SM, Armanini D, Iacobone M, Favia G. Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature. Am Surg. 2005;71(10):864–9.

    PubMed  Google Scholar 

  79. Kasperlik-Zaluska AA, Roslonowska E, Slowinska-Srzednicka J, Otto M, Cichocki A, Cwikla J, et al. 1,111 patients with adrenal incidentalomas observed at a single endocrinological center: incidence of chromaffin tumors. Ann N Y Acad Sci. 2006;1073:38–46.

    Article  CAS  PubMed  Google Scholar 

  80. Ilias I, Pacak K. Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab. 2004;89(2):479–91.

    Article  CAS  PubMed  Google Scholar 

  81. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366(9486):665–75.

    Article  PubMed  Google Scholar 

  82. Eisenhofer G, Bornstein SR, Brouwers FM, Cheung NK, Dahia PL, de Krijger RR, et al. Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer. 2004;11(3):423–36.

    Article  CAS  PubMed  Google Scholar 

  83. Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, et al. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab. 2007;92(10):3822–8.

    Article  CAS  PubMed  Google Scholar 

  84. Dluhy RG. Pheochromocytoma – death of an axiom. N Engl J Med. 2002;346(19):1486–8.

    Article  PubMed  Google Scholar 

  85. Fung MM, Viveros OH, O'Connor DT. Diseases of the adrenal medulla. Acta Physiol (Oxf). 2008;192(2):325–35.

    Article  CAS  Google Scholar 

  86. Kannan S, Remer EM, Hamrahian AH. Evaluation of patients with adrenal incidentalomas. Curr Opin Endocrinol Diabetes Obes. 2013;20(3):161–9.

    Article  CAS  PubMed  Google Scholar 

  87. Szolar DH, Korobkin M, Reittner P, Berghold A, Bauernhofer T, Trummer H, et al. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology. 2005;234(2):479–85.

    Article  PubMed  Google Scholar 

  88. Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92(11):4069–79.

    Article  CAS  PubMed  Google Scholar 

  89. Fassnacht M, Kroiss M, Allolio B. Update in adrenocortical carcinoma. J Clin Endocrinol Metab. 2013;98(12):4551–64.

    Article  CAS  PubMed  Google Scholar 

  90. Lafemina J, Brennan MF. Adrenocortical carcinoma: past, present, and future. J Surg Oncol. 2012;106(5):586–94.

    Article  CAS  PubMed  Google Scholar 

  91. Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, et al. Adrenocortical carcinoma. Endocr Rev. 2014;35(2):282–326.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  92. Roman S. Adrenocortical carcinoma. Curr Opin Oncol. 2006;18(1):36–42.

    Article  PubMed  Google Scholar 

  93. Mork M, Hubosky SG, Roupret M, Margulis V, Raman J, Lotan Y, et al. Lynch Syndrome: A Primer for Urologists and Panel Recommendations. J Urol. 2015;194(1):21–9.

    Article  PubMed  Google Scholar 

  94. Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol. 1984;8(3):163–9.

    Article  CAS  PubMed  Google Scholar 

  95. Schulick RD, Brennan MF. Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol. 1999;6(8):719–26.

    Article  CAS  PubMed  Google Scholar 

  96. Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M, et al. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer. 2005;12(3):667–80.

    Article  CAS  PubMed  Google Scholar 

  97. Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, et al. Metastatic patterns in adenocarcinoma. Cancer. 2006;106(7):1624–33.

    Article  PubMed  Google Scholar 

  98. Branum GD, Epstein RE, Leight GS, Seigler HF. The role of resection in the management of melanoma metastatic to the adrenal gland. Surgery. 1991;109(2):127–31.

    CAS  PubMed  Google Scholar 

  99. Daneshmand S, Quek ML. Adrenal myelolipoma: diagnosis and management. Urol J. 2006;3(2):71–4.

    PubMed  Google Scholar 

  100. Patel VG, Babalola OA, Fortson JK, Weaver WL. Adrenal myelolipoma: report of a case and review of the literature. Am Surg. 2006;72(7):649–54.

    PubMed  Google Scholar 

  101. Bishoff JT, Waguespack RL, Lynch SC, May DA, Poremba JA, Hall CR. Bilateral symptomatic adrenal myelolipoma. J Urol. 1997;158(4):1517–8.

    Article  CAS  PubMed  Google Scholar 

  102. Lam KY, Lo CY. Adrenal lipomatous tumours: a 30 year clinicopathological experience at a single institution. J Clin Pathol. 2001;54(9):707–12.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  103. Meyer A, Behrend M. Presentation and therapy of myelolipoma. Int J Urol. 2005;12(3):239–43.

    Article  PubMed  Google Scholar 

  104. Johnson PT, Horton KM, Fishman EK. Adrenal imaging with MDCT: nonneoplastic disease. AJR Am J Roentgenol. 2009;193(4):1128–35.

    Article  PubMed  Google Scholar 

  105. Kawashima A, Sandler CM, Ernst RD, Takahashi N, Roubidoux MA, Goldman SM, et al. Imaging of nontraumatic hemorrhage of the adrenal gland. Radiographics. 1999;19(4):949–63.

    Article  CAS  PubMed  Google Scholar 

  106. Mearini L, Del Sordo R, Costantini E, Nunzi E, Porena M. Adrenal oncocytic neoplasm: a systematic review. Urol Int. 2013;91(2):125–33.

    Article  CAS  PubMed  Google Scholar 

  107. Tirkes T, Gokaslan T, McCrea J, Sandrasegaran K, Hollar MA, Akisik F, et al. Oncocytic neoplasms of the adrenal gland. AJR Am J Roentgenol. 2011;196(3):592–6.

    Article  PubMed  Google Scholar 

  108. Ricci Z, Chernyak V, Hsu K, Mazzariol FS, Flusberg M, Oh S, et al. Adrenal cysts: natural history by long-term imaging follow-up. AJR Am J Roentgenol. 2013;201(5):1009–16.

    Article  PubMed  Google Scholar 

  109. Guo YK, Yang ZG, Li Y, Deng YP, Ma ES, Min PQ, et al. Uncommon adrenal masses: CT and MRI features with histopathologic correlation. Eur J Radiol. 2007;62(3):359–70.

    Article  PubMed  Google Scholar 

  110. Neri LM, Nance FC. Management of adrenal cysts. Am Surg. 1999;65(2):151–63.

    CAS  PubMed  Google Scholar 

  111. Erickson LA, Lloyd RV, Hartman R, Thompson G. Cystic adrenal neoplasms. Cancer. 2004;101(7):1537–44.

    Article  PubMed  Google Scholar 

  112. Lockhart ME, Smith JK, Kenney PJ. Imaging of adrenal masses. Eur J Radiol. 2002;41(2):95–112.

    Article  PubMed  Google Scholar 

  113. Sanal HT, Kocaoglu M, Yildirim D, Bulakbasi N, Guvenc I, Tayfun C, et al. Imaging features of benign adrenal cysts. Eur J Radiol. 2006;60(3):465–9.

    Article  PubMed  Google Scholar 

  114. Castillo OA, Litvak JP, Kerkebe M, Urena RD. Laparoscopic management of symptomatic and large adrenal cysts. J Urol. 2005;173(3):915–7.

    Article  PubMed  Google Scholar 

  115. Rozenblit A, Morehouse HT, Amis ES. Cystic adrenal lesions: CT features. Radiology. 1996;201(2):541–8.

    Article  CAS  PubMed  Google Scholar 

  116. Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet. 2005;365(9477):2125–36.

    Article  PubMed  Google Scholar 

  117. Auchus RJ, Arlt W. Approach to the patient: the adult with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2013;98(7):2645–55.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  118. Gupta P, Bhalla A, Sharma R. Bilateral adrenal lesions. J Med Imaging Radiat Oncol. 2012;56(6):636–45.

    Article  PubMed  Google Scholar 

  119. McHugh K. Renal and adrenal tumours in children. Cancer Imaging. 2007;7:41–51.

    Article  PubMed Central  PubMed  Google Scholar 

  120. Kushner BH. Neuroblastoma: a disease requiring a multitude of imaging studies. J Nucl Med. 2004;45(7):1172–88.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Urology, University of Utah School of Medicine, Salt Lake City, UT, USA

    Kefu Du MD & Jay T. Bishoff MD, FACS

  2. Department of Urology, Intermountain Medical Center, Murray, UT, USA

    Jay T. Bishoff MD, FACS

  3. Department of Radiology, University of Utah School of Medicine, Salt Lake City, UT, USA

    Marta E. Heilbrun MD, MS

Authors
  1. Kefu Du MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marta E. Heilbrun MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jay T. Bishoff MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jay T. Bishoff MD, FACS .

Editor information

Editors and Affiliations

  1. Focal Therapy and Interventional Urologic Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA

    Ardeshir R. Rastinehad

  2. Department of Radiology, Hofstra North Shore LIJ School of Medici Department of Radiology, New Hyde Park, New York, USA

    David N. Siegel

  3. National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

    Peter A. Pinto

  4. National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

    Bradford J. Wood

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Du, K., Heilbrun, M.E., Bishoff, J.T. (2016). Adrenal Imaging. In: Rastinehad, A., Siegel, D., Pinto, P., Wood, B. (eds) Interventional Urology. Springer, Cham. https://doi.org/10.1007/978-3-319-23464-9_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-23464-9_26

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-23463-2

  • Online ISBN: 978-3-319-23464-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation